ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VAXX Vaxxinity Inc

0.115
-0.0064 (-5.27%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,999,747
Bid Price 0.10
Ask Price 0.143
News -
Day High 0.125

Low
0.1075

52 Week Range

High
3.10

Day Low 0.1075
Share Name Share Symbol Market Stock Type
Vaxxinity Inc VAXX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0064 -5.27% 0.115 23:00:07
Open Price Low Price High Price Close Price Previous Close
0.121 0.1075 0.125 0.1166 0.1214
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,395 1,999,747 US$ 0.1172123 US$ 234,395 - 0.1075 - 3.10
Last Trade Type Quantity Price Currency
18:45:02 formt 260 US$ 0.115 USD

Vaxxinity Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
15.21M 126.75M - 0 -56.93M -0.45 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vaxxinity News

Date Time Source News Article
4/19/202417:53GlobeNewswire Inc.Vaxxinity Issues Shareholder Letter
4/19/202415:27GlobeNewswire Inc.Vaxxinity Announces Intention to Voluntarily Delist and..
3/28/202408:23GlobeNewswire Inc.Vaxxinity to Present Clinical Data at the Annual Academy of..
3/27/202415:41GlobeNewswire Inc.Vaxxinity Reports Fourth Quarter and Full-Year 2023..
3/07/202409:32GlobeNewswire Inc.Vaxxinity Announces Positive Target Engagement Data from..
2/15/202415:15Edgar (US Regulatory)Form 8-K - Current report
2/15/202407:00GlobeNewswire Inc.Vaxxinity’s Cholesterol Vaccine Candidate Successfully..
2/13/202407:00GlobeNewswire Inc.Vaxxinity to Present Clinical and Preclinical Pipeline Data..
2/12/202416:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/30/202407:00GlobeNewswire Inc.Vaxxinity Announces Research Collaboration on Active..
1/18/202407:00GlobeNewswire Inc.Vaxxinity Announces Collaboration on Space Medicine Research..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VAXX Message Board. Create One! See More Posts on VAXX Message Board See More Message Board Posts

Historical VAXX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.480.48180.10750.20318363,276,495-0.365-76.04%
1 Month0.730.7350.10750.27925311,117,858-0.615-84.25%
3 Months0.701.050.10750.4960221734,122-0.585-83.57%
6 Months0.95491.330.10750.6094136488,932-0.8399-87.96%
1 Year1.783.100.10751.02347,511-1.67-93.54%
3 Years16.9022.770.10753.79402,313-16.79-99.32%
5 Years16.9022.770.10753.79402,313-16.79-99.32%

Vaxxinity Description

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.

Your Recent History

Delayed Upgrade Clock